本文選題：慢性阻塞性肺疾病 + 胰石蛋白��； 參考：《遵義醫(yī)學院》2017年碩士論文

【摘要】：目的:觀察血清胰石蛋白(PSP/Reg)在COPD急性期、緩解期及健康體檢者中的表達情況,探討血清胰石蛋白在慢性阻塞性肺疾病急性加重期患者診療中的臨床意義。方法:選取75名急性期COPD患者作為A組,將A組按病情由輕到重分為輕(A1組)、中(A2組)、重(A3組)三組。將A組經治療后癥狀緩解者作為R組,將R組由輕到重分為R1、R2、R3三組。26名健康體檢者作為對照組(H組),將A組中痰培養(yǎng)陽性者作為S組,將S組中癥狀緩解后痰培養(yǎng)轉陰者作為S1組。收集研究對象年齡、性別、CAT評分,收集A、R、H組空腹靜脈血,測定血清PSP/Reg濃度。測定A組入院當天的降鈣素原(PCT)、C-反應蛋白(CRP)、白介素-6(IL-6)、紅細胞沉降率(ESR)、白細胞計數(WBC)、中性粒細胞計數(N)及痰培養(yǎng),痰培養(yǎng)陽性者達到臨床明顯緩解后再次行痰培養(yǎng)檢查。待病情平穩(wěn)后測定肺功能。觀察A組、S組中PSP/Reg與PCT、CRP、IL-6、ESR、WBC、N的相關性。結果:急性期的A組血清PSP/Reg水平顯著高于癥狀緩解后的R組,差異有統(tǒng)計學意義(P0.05);急性期的A組及緩解后的R組血清PSP/Reg水平顯著高于健康對照H組,差異有統(tǒng)計學意義(P0.05);急性期血清PSP/Reg水平在A1、A2、A3各組間差異顯著(P0.05),且呈遞增趨勢;A2、A3、S組經治療后,血清PSP/Reg水平下降明顯,差異有統(tǒng)計學意義(P0.05);急性期血清PSP/Reg水平與CRP正相關(P0.05),與其他指標無相關性(P0.05)。痰培養(yǎng)陽性組血清PSP/Reg水平與CRP呈正相關(P0.05)。結論:血清PSP/Reg有可能可作為評估肺部炎性感染的指標,與PCT、CRP等炎性指標聯(lián)合使用有更好的診斷價值;血清PSP/Reg有可能可作為AECOPD病情評估的有效指標之一,與肺功能、臨床癥狀、急性加重情況聯(lián)合使用更有助于患者病情的評估;血清PSP/Reg水平在治療前后存在顯著差異,可能有助于疾病治療效果的評估。
[Abstract]:Objective: To observe the clinical significance of serum trypsin (PSP/Reg) in patients with acute COPD, remission and health examination, and to explore the clinical significance of serum trypsin in the diagnosis and treatment of acute exacerbation of chronic obstructive pulmonary disease. Methods: 75 patients with acute COPD were selected as A group, and group A was divided into light (A1) from light to weight (A2). Group A (group A3) three groups. Group A was treated as R group after treatment, and group R from light to heavy to R1, R2, R3 in group.26 name as control group (H group). The sputum culture positive in A group was taken as S group. Fasting venous blood, determination of serum PSP/Reg concentration. Determination of calcitonin (PCT), C- reactive protein (CRP), -6 (IL-6), erythrocyte sedimentation rate (ESR), leukocyte count (WBC), neutrophils count (N) and sputum culture in A group. The sputum culture of sputum culture positive patients after clinical obvious remission. The correlation between PSP/Reg and PCT, CRP, IL-6, ESR, WBC, N in group A and group S was observed. Results: the serum PSP/Reg level in the acute phase of the A group was significantly higher than that of the R group after the symptom remission. The levels of serum PSP/Reg in the acute phase of A1, A2, and A3 were significantly different (P0.05) and increased, and the level of serum PSP/Reg decreased significantly in A2, A3, S group after treatment, the difference was statistically significant (P0.05), and there was no correlation between the serum PSP/Reg level and the other indexes in the acute stage. Positive correlation with CRP (P0.05). Conclusion: serum PSP/Reg may be used as an indicator of pulmonary inflammatory infection and is of better diagnostic value combined with PCT, CRP and other inflammatory markers. Serum PSP/Reg may be one of the effective indicators for the assessment of AECOPD, and is more helpful to the combined use of lung power, clinical symptoms and acute exacerbation. There is a significant difference in serum PSP/Reg level before and after treatment, which may be helpful to evaluate the therapeutic effect of the disease.
【學位授予單位】：遵義醫(yī)學院
【學位級別】：碩士
【學位授予年份】：2017
【分類號】：R563.9

【相似文獻】

相關期刊論文 前10條

1 葉國超;11例胰石癥的診治體會[J];中國鄉(xiāng)村醫(yī)藥;2004年03期

2 夏祥厚,朱家勝;胰石癥的診斷與外科治療[J];皖南醫(yī)學院學報;1994年04期

3 陳志海;胰石癥2例報告[J];福建醫(yī)藥雜志;1995年01期

4 李兆全，喬岐祿，張寶善;胰石癥（附6例報告并文獻復習）[J];中國現(xiàn)代醫(yī)學雜志;1995年01期

5 趙桂蘭,施小宇;胰石癥的診斷與治療(附12例報告)[J];浙江醫(yī)學;1998年06期

6 邢樹亮,張東偉,關偉,王國卿;胰石癥8例[J];黑龍江醫(yī)學;1999年06期

7 張喜,侯玉保,張友文,邢濤,徐秋紅,馬玉潔;胰石癥的診治分析[J];現(xiàn)代醫(yī)藥衛(wèi)生;2005年15期

8 丁民謀;巫協(xié)寧;;胰石癥[J];國外醫(yī)學(消化系疾病分冊);1983年03期

9 顧海蓉;自身免疫性胰腺炎反復發(fā)作導致胰石形成[J];胰腺病學;2004年03期

10 白文元;姚希賢;;胰石癥(講座)[J];河北醫(yī)學院學報;1989年S1期

相關碩士學位論文 前1條

1 魏雅茹;血清胰石蛋白在慢性阻塞性肺疾病中的表達及臨床意義[D];遵義醫(yī)學院;2017年

，

本文編號：1956498